MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    NUBPL mutations cause combined dystonia with bilateral striatal necrosis and cerebellar atrophy

    B. Balint, G. Charlesworth, M. Stamelou, L. Carr, N. Wood, K. Bhatia (London, United Kingdom)

    Objective:  To elucidate the genetic cause of a distinct combined dystonia syndrome, inherited in an autosomal recessive fashion in a small UK kindred [Figure1A]. Background:…
  • 2017 International Congress

    Clinical and electrophysiological features of seven patients with moving toes syndrome: Is it a type of spinal segmental myoclonus?

    G. Kiziltan, H. Kurucu, C. Yalcinkaya, A. Gunduz, M. E. Kiziltan (Istanbul, Turkey)

    Objective: We aimed to present a case series of moving toes syndrome to show how clinical presentation and electrophysiological findings may change. Background: The moving…
  • 2017 International Congress

    Management of fragility fractures in Parkinson’s Disease (PD)

    G. Alg, A. Chatterjee (Reading, United Kingdom)

    Objective: To assess the management of osteoporotic fragility fractures in patients with PD attending a Movement disorders clinic. Background: Patients with PD have a high…
  • 2017 International Congress

    End of Life Care in Parkinson’s Disease

    S. Mole, S. Jackson (Exeter, United Kingdom)

    Objective: We aim to identify the current practice at the Royal Devon & Exeter NHS trust of managing Patients with PD at the end of…
  • 2017 International Congress

    Stiff-limb syndrome with cerebellar features and atypical EMG findings responds to IVIG

    S. Rametta, G. Robinson, N. Hellmers, N. Jacoby, H. Sarva (Brooklyn, NY, USA)

    Objective: To describe a case of Stiff-Limb Syndrome with ataxic features which had delayed EMG findings and improvement to IVIG. Background: Stiff-Person Syndrome (SPS) is…
  • 2017 International Congress

    Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease:  results from the Phase 3 study dose-titration phase

    R. Hauser, S. Isaacson, A. Espay, R. Pahwa, D. Truong, E. Pappert, P. Gardzinski, B. Dzyngel, A. Agro, H. Fernandez (Tampa, FL, USA)

    Objective: To determine the dose of APL-130277 required by each patient with Parkinson’s Disease (PD) to turn from OFF to Full ON.  This dose is…
  • 2017 International Congress

    Transcranial direct current stimulation enhances consolidation of learning in Parkinson’s disease

    S. Broeder, E. Nackaerts, E. Heremans, K. Cuypers, R. Meesen, G. Verheyden, A. Nieuwboer (Leuven, Belgium)

    Objective: To examine the effects of training combined with transcranial direct current stimulation (tDCS) on writing performance and consolidation of learning in Parkinson’s disease (PD).…
  • 2017 International Congress

    Study in Parkinson’s Disease of Exercise (SPARX): A Randomized, Controlled Futility Trial

    D. Corcos, C. Moore, W. Kohrt, D. Hall, A. Delitto, C. Comella, D. Josbeno, C. Christiansen, B. Berman, B. Kluger, E. Melanson, S. Jain, J. Robichaud, C. Poon, M. Schenkman (Chicago, IL, USA)

    Objective: Our first objective was to determine whether people with de novo Parkinson’s disease (PD) are able to exercise at either 60-65% maximal heart rate…
  • 2017 International Congress

    Using an Objective Measure of Movement to Quantify Night Time Sleep

    P. Farzanehfar, P. Churchward, M. Horne (Parkville, Australia)

    Objective: To assess whether data obtained from the Parkinson’s KinetiGraph (PKG), an objective movement recording system for Parkinson’s disease (PD), could be used to provide…
  • 2017 International Congress

    Drug utilization characteristics in individuals with early Parkinson’s disease interim analysis of the STEADY-PD III study

    S. Sharma, T. Simuni, B. Greco, K. Biglan, C. Tarolli, K. Hodgeman, D. Oakes, D. Penz (Rochester, NY, USA)

    Objective: To review symptomatic therapy (ST) utilization trends in individuals with early Parkinson’s disease (PD). Background: There are changing trends in ST utilization in early…
  • « Previous Page
  • 1
  • …
  • 123
  • 124
  • 125
  • 126
  • 127
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley